These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. Tuo L, Xiang J, Pan X, Hu J, Tang H, Liang L, Xia J, Hu Y, Zhang W, Huang A, Wang K, Tang N. J Exp Clin Cancer Res; 2019 Feb 04; 38(1):50. PubMed ID: 30717766 [Abstract] [Full Text] [Related]
5. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma. Liu Y, Sun L, Su X, Guo S. Biomed Pharmacother; 2016 Dec 04; 84():237-243. PubMed ID: 27662474 [Abstract] [Full Text] [Related]
6. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Ding J, Wen W, Xiang D, Yin P, Liu Y, Liu C, He G, Cheng Z, Yin J, Sheng C, Zhang W, Nan F, Ye W, Zhang X, Wang H. Oncotarget; 2015 May 10; 6(13):11627-39. PubMed ID: 25890498 [Abstract] [Full Text] [Related]
7. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D, Yun JP. Cancer Lett; 2017 Aug 28; 402():71-80. PubMed ID: 28577975 [Abstract] [Full Text] [Related]
8. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Wang Z, Wei W, Sun CK, Chua MS, So S. Liver Int; 2015 Apr 28; 35(4):1403-15. PubMed ID: 25098386 [Abstract] [Full Text] [Related]
16. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ, Chua MS, Wei W, So SK. Oncotarget; 2015 Oct 06; 6(30):29847-59. PubMed ID: 26359353 [Abstract] [Full Text] [Related]
17. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma. Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP. Oncotarget; 2015 Mar 30; 6(9):6570-83. PubMed ID: 25788265 [Abstract] [Full Text] [Related]
18. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H, Ji L, Xu Z, Fan X, Tong Y, Liu H, Zhao J, Cai X. Cancer Lett; 2020 Mar 31; 473():13-24. PubMed ID: 31875525 [Abstract] [Full Text] [Related]
19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C. Dig Dis Sci; 2017 Jan 31; 62(1):133-142. PubMed ID: 27921263 [Abstract] [Full Text] [Related]
20. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). Tran DDH, Koch A, Allister A, Saran S, Ewald F, Koch M, Nashan B, Tamura T. Cell Signal; 2016 Dec 31; 28(12):1872-1880. PubMed ID: 27619201 [Abstract] [Full Text] [Related] Page: [Next] [New Search]